GPT and metabolic dysfunction-associated steatotic liver disease: Several biomarkers of NAFLD such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), AST/ALT ratio, γ-glutamyltranspeptidase (γ-GT), insulin resistance (IR) have been reported (4, 6).